M.E. van Linde
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma) (NCT03463733) | M.E. van Linde | 2018-03-02 |
Track M.E. van Linde automatically
Every clearance here is in the API, with alerts when new ones post.